Latest News
FairJourney Biologics enter antibody discovery agreement with Pandion Therapeutics using novel discovery platforms
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research Porto, Portugal, Cambridge and London, UK, 23rd November 2020: FairJourney Biologics S.A...
IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squib
IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...
IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency
IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency · Panel of 15 potent antibodies selected that are optimally suited to clinical development and manufacturing · Monoclonal antibodies have the potential to both...
IONTAS featured on BBC Look East
The BBC has this week covered IONTAS's accelerated contribution at finding antibodies to target Covid 19.
FairJourney Biologics enter antibody discovery agreement with Pandion Therapeutics using novel discovery platforms
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research Porto, Portugal, Cambridge and London, UK, 23rd November 2020: FairJourney Biologics S.A...
Novel COVID-19 Antibody Therapy Candidates Identified by Leading UK Biotech Consortium
Novel COVID-19 Antibody Therapy Candidates Identified by Leading UK Biotech Consortium Potent antibody drug combinations identified Candidate antibodies could be used to treat and protect against SARSCoV-2 infections Antibody combinations differentiated from others...
